Written By: David Statman
Mesothelioma pathology is critical step in confirming a mesothelioma diagnosis after a biopsy. It involves the microscopic and molecular evaluation of tissue or fluid samples to identify malignant mesothelial cells and determine whether the patient has mesothelioma or another type of cancer.
Medically Reviewed By
Dr. Stephen Williams
Precision Oncology Scientist
FREE MESOTHELIOMA GUIDE
Mesothelioma packet includes:
FREE Mesothelioma Guide Packet
Medically Reviewed By
Dr. Stephen Williams
Precision Oncology Scientist
JUMP TO A TOPIC
Important Facts About Mesothelioma Pathology
Mesothelioma pathology involves the examination of tissue or fluid samples to confirm the presence of mesothelioma and is performed by specialized pathologists. Mesothelioma is a rare type of cancer that forms in the lining of the lungs, abdominal cavity, or heart.
The diagnostic process for mesothelioma typically begins with imaging studies, such as an X-ray or CT scan, which may reveal abnormalities. However, imaging alone cannot establish a definitive diagnosis. Confirmation requires a biopsy.
A mesothelioma biopsy is a medical procedure in which doctors collect tissue or fluids from the suspected disease site. Following the biopsy, the surgeon sends the tissue or fluid samples to a pathologist, who examines it. The pathologist evaluates the specimen and generates a pathology report outlining the diagnosis and key findings.
Immunohistochemical (IHC) staining is a cornerstone of mesothelioma pathology, allowing pathologists to confirm mesothelial origin, distinguish mesothelioma from metastatic carcinomas, and identify the cell type, which can determine prognosis and treatment. IHC detects specific proteins (markers) expressed by tumor cells using labeled antibodies.
[pathologystaining]
Current immunohistochemical panels combine positive mesothelial markers with negative carcinoma markers (e.g., TTF-1, Napsin A, CEA, MOC-31) to improve diagnostic accuracy. In addition, molecular tests such as loss of BAP1 expression or MTAP loss (surrogate for CDKN2A deletion), are increasingly used to confirm a diagnosis of mesothelioma or help differentiate it from non-cancerous mesothelial growths.
There are multiple sections to a mesothelioma pathology report, which can be long and complex. The most essential parts include the descriptions of the tissue or fluid samples, and the pathologist’s findings and final interpretation.
The mesothelioma pathology report includes:
This report is based on data compiled from either a histology test or a cytology test (or both). Histology and cytology are separate medical terms within pathology testing and reports. The type of biopsy performed (tissue or fluid) will determine which testing is done by the pathologist.
Cytology, also referred to as cytopathology, is the study of individual cells or a small cluster of cells and their characteristics. Mesothelioma cytology focuses on analyzing fluid samples – most commonly pleural or peritoneal effusions, an accumulation of excess fluid in the lining of the lungs or abdominal cavity – to assess for the presence of malignant mesothelial cells.
To obtain these samples, physicians use a needle to drain the fluid from the pleural or peritoneal space. The collected fluid is then processed and stained so pathologists can examine how the cells react to specific stains and immunohistochemical markers.
Obtaining fluid for cytology is less invasive than a tissue biopsy because it often does not require surgery. However, establishing a definitive diagnosis of mesothelioma using fluid alone remains difficult and unreliable. Effusion samples often lack the number of cells needed to accurately interpret the tissue architecture to make a definitive diagnosis.
As a result, cytology is typically used as an initial or supportive diagnostic tool. When clinical suspicion remains high or cytology is inconclusive, most specialists rely on tissue biopsy and histologic analysis for definitive mesothelioma diagnosis.
Histology, also known as histopathology, is the microscopic examination of tissue to identify diseases like cancer, including mesothelioma. Mesothelioma histology is the gold standard for the diagnosis of this cancer because it allows pathologists the ability to evaluate both cellular features and tissue architecture.
For histologic testing, tissue can be obtained either through an open surgical biopsy, which involves a larger incision, or a needle biopsy, which requires a smaller, image-guided approach. The tissue sample is processed and examined under a microscope for malignant cells.
Histology may be performed alongside cytology to assess both tissue and fluid samples, but tissue-based analysis is more definitive. Tissue specimens typically contain a higher number of intact cells arranged in recognizable patterns, making malignancy easier to identify.
Pathologists apply special stains, including immunohistochemical markers, to confirm the presence of mesothelioma and determine the histologic subtype (epithelioid, sarcomatoid, or biphasic). Identifying the cell type is essential, as it directly influences prognosis, treatment decisions, and clinical trial eligibility.
One of the main reasons for a mesothelioma pathology report is to determine the cell type. Mesothelioma tumors can be made up of three cell variations, each with their own unique qualities and effects on prognosis.
Epithelioid mesothelioma is the most common cell type. The cells are typically uniform and oval in shape, with distinct cell borders, a visible nucleus, and abundant eosinophilic (pink) cytoplasm. This cell type generally has the most favorable prognosis because the cells tend to grow cohesively, making tumors more responsive to surgery and systemic therapy.
Sarcomatoid mesothelioma is the least common and most aggressive cell type. The cells are spindle-shaped, poorly cohesive, and often arranged in disorganized patterns with elongated nuclei. Since these cells spread more diffusely and do not cluster tightly, sarcomatoid mesothelioma is more difficult to treat and is associated with a poorer prognosis.
Biphasic mesothelioma contains both epithelioid and sarcomatoid cells, with at least 10% of each required for this classification. Prognosis and treatment response depend on the percentage of each cell type, with outcomes generally improving if there are more epithelioid cells than sarcomatoid cells.
Pathologists analyze tissue and fluid samples extracted from biopsies. Mesothelioma pathology explicitly tests these samples for diseased mesothelial cells, which can form clumps called tumors. Pathologists examine cells under a microscope and use a staining process to detect cancerous proteins specific to mesothelioma.
The pathology report includes the patient’s name and other identifiable information, medical history, the pathologist’s description of the biopsy sample without using a microscope, the microscopic characteristics of the cells, and the diagnosis.
Pathology is the scientific process to determine if the sample removed from a biopsy includes mesothelioma. Pathologists are integral to properly diagnosing this disease. Pathology also can determine the cell type and occasionally the stage of the cancer.
Sources & Author
Mesothelioma pathology is a vital process used to confirm a diagnosis of mesothelioma, a rare form of cancer that affects the linings of the lungs, abdomen, or heart. After a doctor suspects mesothelioma based on imaging tests, a biopsy is performed to collect tissue or fluid samples from the affected area. These samples are then examined by specialized pathologists who analyze their microscopic features to determine if cancerous mesothelial cells are present. This detailed examination is essential because imaging alone cannot provide a definitive diagnosis.
In mesothelioma pathology, laboratory techniques such as immunohistochemical staining are fundamental. This method uses antibodies to detect specific proteins expressed by mesothelioma cells, helping to distinguish mesothelioma from other types of cancer. Some common markers include calretinin, WT1, and podoplanin, which are typically found in mesothelioma cells, while other markers are used to rule out alternative diagnoses. Cytology, the study of individual cells in fluid samples, and histology, the analysis of tissue architecture, are both used to provide comprehensive information. Tissue samples often give more accurate and detailed insights, making histology the gold standard for diagnosis.
The pathology report generated from these examinations provides crucial information for the diagnosis. It details the source and type of the biopsy sample, describes its appearance both to the naked eye and under the microscope, and offers a conclusive interpretation. The report also identifies the specific cell type of the tumor, which can be epithelioid, sarcomatoid, or biphasic, each influencing prognosis and treatment options. Understanding the cell type helps doctors develop personalized treatment plans and evaluate eligibility for clinical trials. Overall, mesothelioma pathology is a carefully conducted process that ensures an accurate diagnosis, guiding patients and families through their health journey with clarity and confidence.
